Eisai provided 2.28 Bn free doses of diethylcarbamazine to treat patients in 30 low-income countries
Register to read the full analysis —or— Upgrade to access more features
#coverage
#available
#uninsured
#availability
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.